Work

Successful Treatment of Pembrolizumab-associated Myositis-myocarditis-myasthenia Gravis Overlap Syndrome with Gastrointestinal Pseudo-obstruction Using Zilucoplan: A Case Report

Year: 2026
Type: article
Study design: Case Report
Abstract: Myositis-myocarditis-myasthenia gravis (MMM) overlap syndrome is a rare, potentially fatal complication of immune checkpoint inhibitor (ICI) therapy. We report a 74-year-old man with pre-existing thymoma and anti-acetylcholine receptor antibody positivity who developed pembrolizumab-induced MMM complicated by gastrointestinal pseudo-obstruction (GIPO). Despite the administration of corticosteroids and intravenous immunoglobulin, ocular symptoms persisted, and bowel dysmotility progressed. We initiated zilucoplan, a complement C5 inhibitor. Within days, diplopia and dysphagia resolved, and GIPO markedly improved on radiography, enabling oral intake. To our knowledge, this is the first case of pembrolizumab-induced MMM treated with zilucoplan and the first ICI-mediated GIPO managed with a complement inhibitor.
Language: English
Subfield: Oncology
Field: Medicine
Open Access status: diamond
OpenAlex ID: W7236040167
FWCI:
Cites: 22
Cited by:
Related to: 10